News | December 20, 2023
Venus Remedies' R3SET forays into wellness
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Expands patient reach to remotest towns by furthering investment in GoApptiv
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
New facility is part of Aptar Pharma’s global expansion program
Express Scripts to add Zepbound to National Preferred Formulary
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Subscribe To Our Newsletter & Stay Updated
